Startups
BrainXell focuses on neural cells for therapeutic development. Founded in 2015 by Prof. Su-Chun Zhang with help from the Discovery to Product (D2P) program of University of Wisconsin Madison, it is based on the proprietary technology of directed differentiation of human stem cells (including induced pluripotent stem cells) to highly enriched subclasses of neurons. BrainXell is developing drug discovery / toxicology testing platforms using patient-derived or genetically modified stem cells and provides large-scale production of highly enriched, functionally specialized neural cells to the pharmaceutical and biotechnology industry.
BrainXell also aims to develop stem cell therapy for neurological injuries and diseases through collaboration with pharmaceutical and healthcare industry. BrainXell’s mission is to make our brain healthy and well.
BrainXell also aims to develop stem cell therapy for neurological injuries and diseases through collaboration with pharmaceutical and healthcare industry. BrainXell’s mission is to make our brain healthy and well.
Overview
Location
United States, Wisconsin, Madison
Employees
11-50
Founded date
2015
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 8, 2016 | Silatronix, Propeller, BrainXell, & More: This Week’s WI Watchlist | Share Share on Facebook Share on Twitter LinkedIn Email Reprints The 2016 presidential campaign is coming to a close and for many, not a day too soon. Renew your faith in humanity with these recent headlines from Wisconsin’s innovation comm... |
Reviews 0
FAQ about BrainXell, Inc.
When was BrainXell, Inc. founded?
BrainXell, Inc. was founded in 2015.
What has the press written about BrainXell, Inc.?
Parsers VC has collected 2 articles mentioning BrainXell, Inc., among them “Silatronix, Propeller, BrainXell, & More: This Week’s WI Watchlist” (Nov 8, 2016).
Is BrainXell, Inc. still active?
Yes, BrainXell, Inc. is active; its latest activity on Parsers VC dates from May 7, 2026.